Jeffrey Allen Bailey

Chief Commercial Officer, KING PHARMACEUTICALS INC.

Companies

Aurinia Pharmaceuticals Inc.Board member Aug 21, 2023 to now¹
Rein Therapeutics, Inc.Board member Mar 19, 2018 to Jun 17, 2022²
BIODELIVERY SCIENCES INTERNATIONAL INCChief executive officer May 12, 2020 to Mar 22, 2022³
BIODELIVERY SCIENCES INTERNATIONAL INCBoard member Mar 17, 2020 to Mar 22, 2022⁴
abrdn World Healthcare FundBoard member Aug 28, 2020 to Apr 8, 2021⁵
abrdn Healthcare InvestorsBoard member Aug 28, 2020 to Sep 23, 2020⁶
abrdn Life Sciences InvestorsBoard member Aug 28, 2020 to Sep 23, 2020⁷
abrdn Healthcare Opportunities FundBoard member Aug 28, 2020 to Sep 23, 2020⁸
Lantheus Holdings, Inc.Board member Jun 24, 2015 to Sep 3, 2015⁹
Lantheus Holdings, Inc.Chief executive officer Jun 24, 2015 to Sep 3, 2015⁹
Lantheus Holdings, Inc.President Jun 24, 2015 to Sep 3, 2015⁹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Nov 21, 2025Shares withheld for tax 2,716 shares at $15.68 of Aurinia Pharmaceuticals Inc.¹⁰
Nov 21, 2024Granted 12,135 shares of Aurinia Pharmaceuticals Inc.¹²
Nov 11, 2024Sold 4,557 shares at $8.43 of Aurinia Pharmaceuticals Inc.¹³
Nov 8, 2024Exercised options 17,913 shares of Aurinia Pharmaceuticals Inc.¹³
Mar 22, 2022Other 105,133 shares of BIODELIVERY SCIENCES INTERNATIONAL INC¹¹
Mar 9, 2022Exercised options 5,333 shares of BIODELIVERY SCIENCES INTERNATIONAL INC¹⁴
Nov 4, 2021Exercised options 53,333 shares of BIODELIVERY SCIENCES INTERNATIONAL INC¹⁵

The numbers on this page point here. Each one links to the record it came from.